Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-year comparison of quetiapine XR vs risperidone on subjective well-being in schizophrenia outpatients
2007-004740-79Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in schizophrenia comparing Quetiapine XR with Risperidone (2 arms). Primary endpoint: Responder rate on SWN-K at month 6. Started Nov 2007; status: completed.
02
Drugs
quetiapinerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-004740-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004740-79.